Heliyon · 2024 · 17 citations · 29 references
Life SciencesMedicinal ChemistryPharmacologyDrug DiscoveryStructural BiologyStructure-activity RelationshipsBacterial PathogenesisBacterial Virulence FactorsEnzyme InhibitionMolecular DockingProtein DockingProtein-ligand DockingBiofilm-associated Virulence RegulationFlexible AlignmentMolecular Docking AnalysisNovel Antibacterial Drug DiscoveryVirulence Determinants
Staphylococcus aureus is a highly prevalent and aggressive human pathogen causing a wide range of infections. This study aimed to explore the potential of Patuletin, a rare natural flavone, as an anti-virulence agent against S . aureus . At a sub-inhibitory concentration (1/4 MIC), Patuletin notably reduced biofilm formation by 27 % and 23 %, and decreased staphyloxanthin production by 53 % and 46 % in Staphylococcus aureus isolate SA25923 and clinical isolate SA1, respectively. In order to gain a more comprehensive understanding of the in vitro findings, several in silico analyses were conducted. Initially, a 3D-flexible alignment study demonstrated a favorable structural similarity between Patuletin and B70 , the co-crystallized ligand of CrtM, an enzyme that plays a pivotal role in the biosynthesis of staphyloxanthin. Molecular docking highlighted the strong binding of Patuletin to the active site of CrtM, with a high affinity of −20.95 kcal/mol. Subsequent 200 ns molecular dynamics simulations, along with MM-GBSA, ProLIF, PLIP, and PCAT analyses, affirmed the stability of the Patuletin-CrtM complex, revealing no significant changes in CrtM's structure upon binding. Key amino acids crucial for binding were also identified. Collectively, this study showcased the effective inhibition of CrtM activity by Patuletin in silico and its attenuation of key virulence factors in vitro , including biofilm formation and staphyloxanthin production. These findings hint at Patuletin's potential as a valuable therapeutic agent, especially in combination with antibiotics, to counter antibiotic-resistant Staphylococcus aureus infections.
29
PLIP: fully automated protein–ligand interaction profiler
Sebastian Salentin, Sven B. Schreiber, V. Joachim Haupt et al. · Nucleic Acids Research · 2015 · 2.3K citations · Full text
Role of Molecular Dynamics and Related Methods in Drug Discovery
Marco De Vivo, Matteo Masetti, Giovanni Bottegoni et al. · Journal of Medicinal Chemistry · 2016 · 1.3K citations · Full text
Elena Papaleo, Paolo Mereghetti, Piercarlo Fantucci et al. · Journal of Molecular Graphics and Modelling · 2009 · 605 citations